Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 4/20 | 0.47 |
| ▸ | NPY1R | P25929 | 3/20 | 0.47 |
| ▸ | NPY4R | P50391 | 3/20 | 0.47 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.45 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.43 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.43 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.43 |
| ▸ | BECN1 | Q14457 | 1/20 | 0.43 |
| ▸ | KDM1A | O60341 | 3/20 | 0.42 |
| ▸ | RAMP3 | O60896 | 6/20 | 0.42 |
| ▸ | CALCR | P30988 | 6/20 | 0.42 |
| ▸ | NPY2R | P49146 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | KDM5A | P29375 | 1/20 | 0.41 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.41 |
| ▸ | TFPI | P10646 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31195953 | 0.92 | MAPK8 (0.49) | NPY5RNPY1RNPY4RKEAP1MAPK8 | |
| SCHEMBL31181269 | 0.89 | NPY4R (0.48) | NPY5RNPY1RNPY4RKEAP1MAPK8 | |
| SCHEMBL30440026 | 0.88 | MAPK8 (0.46) | NPY5RNPY1RNPY4RKEAP1MAPK8 | |
| SCHEMBL38655078 | 0.87 | MAPK8 (0.48) | NPY5RNPY1RNPY4RKEAP1MAPK8 | |
| SCHEMBL16421661 | 0.87 | KEAP1 (0.44) | NPY5RNPY1RNPY4RKEAP1MAPK8 | |
| SCHEMBL31437188 | 0.86 | KEAP1 (0.50) | NPY5RNPY1RNPY4RKEAP1MAPK8 | |
| SCHEMBL30974427 | 0.85 | KDM1A (0.43) | NPY5RNPY1RNPY4RKEAP1MAPK8 | |
| SCHEMBL29687469 | 0.85 | MAPK8 (0.48) | NPY5RNPY1RNPY4RKEAP1MAPK8 | |
| SCHEMBL29568642 | 0.85 | KEAP1 (0.52) | NPY5RNPY1RNPY4RKEAP1MAPK8 | |
| SCHEMBL29825310 | 0.83 | MAPK8 (0.44) | NPY5RNPY1RNPY4RKEAP1MAPK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12618835-B2 | Multiplex microelectrode array for detection of proteases as biomarkers | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2026-05-05 | — | — | US | disclosed |
| US-20220349880-A1 | MULTIPLEX MICROELECTRODE ARRAY FOR DETECTION OF PROTEASES AS BIOMARKERS | UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF NASA | 2022-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12618835-B2 | Multiplex microelectrode array for detection of proteases as biomarkers | APAF1, ADAM33, UCHL1 | NPY5R 2691/4885NPY1R 1831/4885NPY4R 2935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.